Omega Healthcare Investors, Inc.

OHI Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.

46.98 0.14 +0.30%
Market cap
$14.2B
P/E
16.6×
Fwd P/E
19.0×
Dividend yield
7.18%
F-score
6/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Total buys 1.36
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 2 — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 14,190.00
Revenue 1,282.01
Net Income 895.17
Free Cash Flow 832.24
Net Debt (178.21)
Current Ratio 6.03
Debt/Equity 0.00
P/E ratio 16.59
Fwd P/E 19.00
P/S ratio 10.94 (above 10: high)
P/B ratio 2.49
Past 5Y EPS Growth 22.61% (at or above 15%: strong)
This Y EPS Growth 36.74% (at or above 15%: strong)
Next Y EPS Growth (23.84%) (below 0%: weak)
Next Y revenue growth (8.66%) (below 0%: weak)
Next 5Y EPS Growth 2.22%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 15.46%
10-year low 10-year high
P/S against its own 10 years 93.10%
10-year low 10-year high
P/B against its own 10 years 94.09%
10-year low 10-year high
EV/Sales against its own 10 years 4.15%
10-year low 10-year high
EV/FCF against its own 10 years 6.89%
10-year low 10-year high

Dividends

Payout Ratio 1.20
Annual Dividend Rate 3.37
Annual Dividend Yield 7.18%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 2.70
0.67
0.67
0.68
0.68
2025 2.68
0.67
0.67
0.67
0.67
2024 2.68
0.67
0.67
0.67
0.67
2023 2.68
0.67
0.67
0.67
0.67
2022 2.68
0.67
0.67
0.67
0.67
2021 2.68
0.67
0.67
0.67
0.67
2020 2.68
0.67
0.67
0.67
0.67
2019 2.65
0.66
0.66
0.66
0.67
2018 2.64
0.66
0.66
0.66
0.66
2017 2.54
0.62
0.63
0.64
0.65
2016 2.36
0.57
0.58
0.60
0.61
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 445 549 55 184
Receivables 288 345 340 546
Inventory — — — —
Other — — — —
1,944 2,322 1,776 2,097
2023 2024 2025 Q'26
Payables — — — —
ST’ Debt — — — —
Other — — — —
288 328 353 348

Compound Annual Growth %

10y 5y 3y
Sales 4.81% 5.93% 10.66%
Cash Flow 6.93% 4.40% 11.98%
Earnings 10.17% 29.99% 10.46%
Book Value 2.87% 6.15% 12.67%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.47 1.19 — — —
’25 0.33 0.46 0.59 0.55 1.94
’24 0.27 0.45 0.42 0.41 1.55
’23 0.15 0.25 0.37 0.22 1.00
’22 0.79 0.38 0.43 0.19 1.80
’21 0.69 0.36 0.58 0.14 1.75
’20 0.39 0.43 (0.40) 0.27 0.70
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 323 328 — — —
’25 277 283 312 319 1,190
’24 243 253 276 279 1,051
’23 218 250 242 239 950
’22 249 245 239 145 878
’21 274 257 282 250 1,063
’20 253 256 119 264 892
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 216 218 — — —
’25 182 239 227 231 879
’24 151 184 185 229 749
’23 111 170 171 165 618
’22 132 173 167 154 626
’21 176 202 187 157 722
’20 139 190 181 197 708
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 78 655 — — —
’25 88 (107) 217 (117) 81
’24 117 80 82 (44) 234
’23 92 7 90 84 273
’22 333 211 (264) 51 331
’21 (432) 173 88 137 (34)
’20 98 135 162 102 496
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Price, $
Price, $ Low 26.96 26.43 24.90 33.39 13.33 27.06 24.81 25.61 27.53 35.04 +3.0% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
High 38.09 35.14 38.34 45.01 45.22 39.31 33.71 34.77 44.42 46.36 +2.2% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
People
People Employees 60 59 51 49 68 70 52 57 60 69 +1.6% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
Revenue/emp, $m 15.01 15.40 17.29 18.96 13.12 15.18 16.89 16.66 17.52 17.25 +1.6% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
Income, $m
Income, $m Revenue 901 908 882 929 892 1,063 878 950 1,051 1,190 +3.1% 1,087 1,167 1,211 +0.6%
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.0 pt
EBT 384 106 297 344 162 416 436 256 421 624 +5.5%
EBT margin, % 42.66 11.66 33.63 37.02 18.19 39.15 49.66 26.92 40.02 52.47 +9.8 pt
Net income 383 105 294 352 164 428 439 249 418 609 +5.3%
Depreciation 265 295 280 305 327 376 340 334 317 326 +2.4%
Per share, $
Per share, $ Revenue 4.70 4.59 4.40 4.35 3.92 4.49 3.72 3.95 4.07 4.08 (1.6%)
Earnings 1.91 0.51 1.41 1.60 0.70 1.76 1.81 1.01 1.57 1.96 +0.3%
Cash flow 3.26 2.92 2.49 2.59 3.11 3.05 2.65 2.57 2.90 3.01 (0.9%)
Capex (5.58) (2.39) (1.37) (2.67) (0.93) (3.19) (1.25) (1.43) (2.00) (2.73) (7.6%)
Free cash flow (2.32) 0.54 1.12 (0.08) 2.18 (0.14) 1.40 1.13 0.91 0.28 n/m
Book value 21.96 19.66 18.80 20.32 17.72 17.34 16.10 15.64 18.33 18.65 (1.8%)
Shares, m 192 198 200 213 228 237 236 240 258 292 +4.8%
Valuation, ×
Valuation, × P/E 16.82 54.86 25.11 26.47 51.15 16.72 15.53 31.16 24.11 22.74 28.5
P/S 6.80 5.97 7.98 9.73 9.27 6.60 7.52 7.81 9.29 10.87 8.2
P/B 1.45 1.40 1.87 2.08 2.05 1.71 1.74 1.97 2.07 2.38 1.9
EV/Sales 11.53 10.90 13.12 15.22 14.87 11.52 13.20 12.68 13.37 11.02 12.7
EV/FCF (23.37) 93.56 51.42 (848.56) 26.74 (362.68) 34.98 44.15 60.07 161.84 (76.2)
Cash, $m
Cash, $m Operating cash flow 625 578 499 554 708 722 626 618 749 879 +3.9%
Capex (1,069) (472) (274) (570) (212) (756) (294) (345) (515) (797) (3.2%)
Free cash flow (444) 106 225 (17) 496 (34) 331 273 234 81 n/m
Balance, $m
Balance, $m Working capital 626 752 484 522 782 1,064 1,262 1,657 1,994 1,423 +9.6%
Total debt 4,367 4,572 4,541 5,136 5,169 5,254 5,287 5,067 4,839 4,256 (0.3%)
Net debt 4,260 4,475 4,529 5,103 5,002 5,229 4,986 4,623 4,290 4,201 (0.2%)
Shareholders’ equity 4,212 3,888 3,764 4,337 4,037 4,108 3,803 3,762 4,731 5,440 +2.9%
Returns, %
Returns, % ROA 4.33 1.13 3.24 3.71 1.65 4.36 4.61 2.69 4.40 5.93 +1.6 pt
ROIC 4.13 2.36 3.56 3.28 2.63 3.48 2.22 2.92 4.32 4.65 +0.5 pt
ROE 8.82 2.48 7.36 8.42 3.81 10.23 11.09 6.59 9.85 11.63 +2.8 pt
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 25 Oct 2026

Omega Healthcare Investors, Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
VTR Ventas, Inc. $45.2B 154× 140× +21.73% (above 0%: growing) −6.67% (below 0%: shrinking) +13.60% (above 0%: growing) 95.22% 13.43% Compare
OHI Omega Healthcare Investors, Inc. $14.2B 16.6× 19.0× +16.19% (above 0%: growing) +163.04% (above 0%: growing) +710.56% (above 0%: growing) 100.00% 57.45%
DOC Healthpeak Properties, Inc. $13.4B 54.5× 40.2× +11.12% (above 0%: growing) +60.00% (above 0%: growing) −30.47% (below 0%: shrinking) 56.83% 16.18% Compare
AHR American Healthcare REIT, Inc. $11.6B 78.7× 86.5× +24.29% (above 0%: growing) +166.67% (above 0%: growing) +9.53% (above 0%: growing) 20.35% 6.29% Compare
CTRE CareTrust REIT, Inc. $8.6B 22.8× 23.4× +43.46% (above 0%: growing) +5.56% (above 0%: growing) +88.99% (above 0%: growing) 98.66% 67.53% Compare
HR Healthcare Realty Trust Incorporated $6.2B — (loss-making) — (loss-making) −5.26% (below 0%: shrinking) n/m −28.80% (below 0%: shrinking) 64.88% 13.83% Compare
SBRA Sabra Healthcare REIT, Inc. $5.0B 76.0× 48.8× +24.70% (above 0%: growing) n/m −666.09% (below 0%: shrinking) 100.00% (13.59%) Compare
NHI National Health Investors, Inc. $3.3B 19.3× 16.5× +33.81% (above 0%: growing) +45.57% (above 0%: growing) +2,585.45% (above 0%: growing) 72.18% 41.09% Compare
LTC LTC Properties, Inc. $2.4B 16.3× 23.6× +64.11% (above 0%: growing) +72.73% (above 0%: growing) −213.92% (below 0%: shrinking) 100.00% 31.24% Compare
Median of peers $7.4B 54.5× 40.2× +24.50% +52.78% −9.63% 83.70% 15.01%

All 17 Reit Healthcare Facilities stocks →

Pay and ownership Proxy statement filed 21 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 14.02m 32.01m 183.00
2024 13.55m 41.82m 136.00
2023 12.15m 22.49m 102.00
2022 11.00m 21.79m 85.00
2021 10.37m (5.36m) 82.00

Ownership

Directors and executive officers, together 1.70%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Omega Healthcare Investors, Inc. (OHI) Latest News

28 Oct

31 Jul

29 Jan

stockrow.com/OHI · Data as of Oct 25, 2026 · For information only; not investment advice. · © 2026 stockrow.com